NK NK NK cell activating fusion protein NK cells and pharmaceutical compositions comprising the same

摘要

The present invention relates to fusion proteins for cancer treatment and uses thereof. Fusion proteins for preventing or treating cancer of the present invention include antibodies or fragments thereof that bind to tumor associated antigens; Linker; And a fusion polypeptide comprising a natural killer cell-derived protein of CXCL16, which significantly enhances the influx of natural killer cells into cancers expressing specific antigens when co-administered with natural killer cells that are immunocytotherapeutic agents. Effect.